Published in Ann Surg Oncol on December 03, 2008
Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study. J Exp Clin Cancer Res (2013) 0.86
Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction. Dig Dis Sci (2011) 0.84
Outcomes of Abdominal Total Gastrectomy for Type II and III Gastroesophageal Junction Tumors: Single Center's Experience in Korea. J Gastric Cancer (2012) 0.81
Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis. World J Gastroenterol (2014) 0.80
Transthoracic versus abdominal-transhiatal resection for treating Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis. Int J Clin Exp Med (2015) 0.80
Comparison of Clinicopathological Characteristics in the Patients with Cardiac Cancer with or without Esophagogastric Junctional Invasion: A Single-Center Retrospective Cohort Study. Int J Surg Oncol (2013) 0.77
Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution retrospective cohort study. Chin J Cancer Res (2016) 0.75
Progress and limitations of surgery in improving outcomes of esophagogastric junction cancer. Ann Surg Oncol (2009) 0.75
Esophagojejunal anastomosis leakage after total gastrectomy for esophagogastric junction adenocarcinoma: options of treatment. J Gastrointest Oncol (2016) 0.75
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer. J Proteome Res (2010) 1.81
Transradial access compared with femoral puncture closure devices in percutaneous coronary procedures. Int J Cardiol (2008) 1.45
Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest (2007) 1.39
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials. Breast Cancer Res Treat (2007) 1.30
Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterology (2009) 1.30
HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care. Clin Cancer Res (2011) 1.19
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer (2009) 1.17
Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol (2006) 1.17
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials. Cancer (2009) 1.13
The importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of multiple sclerosis patients with mild and moderate disability. Neurol Sci (2011) 1.09
Feasibility of hanging maneuvers in orthotopic liver transplantation with inferior vena cava preservation and in liver surgery. J Hepatobiliary Pancreat Surg (2004) 1.08
Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas. PLoS One (2008) 1.08
Both mucosal and cutaneous papillomaviruses are in the oral cavity but only alpha genus seems to be associated with cancer. J Clin Virol (2012) 1.07
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. Breast Cancer Res (2008) 1.06
Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli. Antimicrob Agents Chemother (2009) 1.05
Clinical features and outcome of familial chronic lymphocytic leukemia. Haematologica (2006) 1.05
An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. Pediatr Infect Dis J (2012) 1.05
Chromogenic in situ hybridization to detect HER-2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab era. Oncologist (2006) 1.05
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med (2011) 1.04
High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med (2011) 1.04
Modified liver hanging maneuver during orthotopic liver transplantation with inferior vena cava preservation. Transplantation (2003) 1.04
Extended multiorgan resection for T4 gastric carcinoma: 25-year experience. J Surg Oncol (2005) 1.03
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. Mov Disord (2006) 1.02
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. Oncology (2009) 1.02
The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion. World J Surg (2014) 1.01
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials. J Exp Clin Cancer Res (2010) 1.00
Solitary fibrous tumor of the liver. J Hepatobiliary Pancreat Surg (2005) 0.99
Simultaneous repair of abdominal aortic aneurysm and resection of unexpected, associated abdominal malignancies. J Surg Oncol (2004) 0.98
Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials. Lung Cancer (2008) 0.97
Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn (2009) 0.96
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. J Exp Clin Cancer Res (2011) 0.96
Liver metastases from breast cancer. Results of surgical resection. Hepatogastroenterology (2002) 0.95
Nosology and inheritance pattern(s) of joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type: a study of intrafamilial and interfamilial variability in 23 Italian pedigrees. Am J Med Genet A (2014) 0.95
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials. BMC Cancer (2010) 0.94
HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant. Am J Surg Pathol (2007) 0.94
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation. Cancer Chemother Pharmacol (2007) 0.93
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. J Hematol Oncol (2013) 0.91
Giant hydatid cyst of the liver with a retroperitoneal growth: a case report. J Med Case Rep (2012) 0.91
Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma. Cancer Lett (2005) 0.91
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL). Leuk Res (2011) 0.91
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area. Radiother Oncol (2007) 0.90
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center. J Exp Clin Cancer Res (2011) 0.90
The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy. J Neurol (2005) 0.89
Paraganglioma of the nasal cavity: a case report. Eur Arch Otorhinolaryngol (2003) 0.88
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study. Breast Cancer Res Treat (2014) 0.88
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study. J Neurooncol (2010) 0.87
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia. Mov Disord (2005) 0.87
Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type). Clin Exp Rheumatol (2012) 0.87
Dermoscopy of pigmented lesions of the vulva: a retrospective morphological study. Dermatology (2011) 0.87
Malignant haemangiopericytoma of the mesorectum. Chir Ital (2005) 0.87
Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials. Cancer (2008) 0.87
Total abdominal approach for postero-superior segments (7, 8) in laparoscopic liver surgery: a multicentric experience. Updates Surg (2015) 0.86
Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer. Expert Opin Pharmacother (2013) 0.86
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia. Eur J Haematol (2010) 0.86
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study. Anticancer Drugs (2007) 0.86
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. J Thorac Oncol (2012) 0.86
Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology (2004) 0.86
Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study. Support Care Cancer (2011) 0.86
Laparoscopic surgery for gastric cancer: preliminary experience. Gastric Cancer (2005) 0.86
Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer. Oncologist (2007) 0.85
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation. BMC Cancer (2009) 0.85
Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases. Anticancer Res (2003) 0.85
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients. Cancer Chemother Pharmacol (2005) 0.85
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series. Breast Cancer Res Treat (2014) 0.85
Early-onset colorectal cancer patients without family history are "at very low risk" for lynch syndrome. J Exp Clin Cancer Res (2014) 0.84
Robotic liver surgery: preliminary experience in a tertiary hepato-biliary unit. Updates Surg (2015) 0.84
Prevalence and Determinants of Tinnitus in the Italian Adult Population. Neuroepidemiology (2015) 0.84
Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease. J Neurooncol (2013) 0.84
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC Cancer (2011) 0.84
Clinical role of p16INK4a expression in liquid-based cervical cytology: correlation with HPV testing and histologic diagnosis. Am J Clin Pathol (2008) 0.84
Bridging and downstaging to transplantation in hepatocellular carcinoma. Future Oncol (2014) 0.84
Results of a pancreatectomy with a limited venous resection for pancreatic cancer. Surg Today (2008) 0.83
Isolated pancreatic metastasis of extremity myxoid liposarcoma: Report of a case. Jpn J Clin Oncol (2006) 0.83
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia. Eur J Haematol (2009) 0.83
Cutaneous melanoma follow-up: appropriateness of requests for ultrasound tests--the S.Gallicano National Referral Centre Experience. J Exp Clin Cancer Res (2013) 0.83
Delayed massive arterial hemorrhage after pancreaticoduodenectomy for cancer. Management of a life-threatening complication. Hepatogastroenterology (2003) 0.83
Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers. J Exp Clin Cancer Res (2009) 0.83